Literature DB >> 18163027

Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.

Caterina Silva1, James C Moon, Andrew G Elkington, Anna S John, Raad H Mohiaddin, Dudley J Pennell.   

Abstract

Late gadolinium enhancement cardiovascular magnetic resonance (CMR) can visualize myocardial interstitial abnormalities. The aim of this study was to assess whether regions of abnormal myocardium can also be visualized by late enhancement gadolinium CMR in the specific cardiomyopathies. A retrospective review of all referrals for gadolinium CMR with specific cardiomyopathy over 20 months. Nine patients with different specific cardiomyopathies were identified. Late enhancement was demonstrated in all patients, with a mean signal intensity of 390 +/- 220% compared with normal regions. The distribution pattern of late enhancement was unlike the subendocardial late enhancement related to coronary territories found in myocardial infarction. The affected areas included papillary muscles (sarcoid), the mid-myocardium (Anderson-Fabry disease, glycogen storage disease, myocarditis, Becker muscular dystrophy) and the global sub-endocardium (systemic sclerosis, Loeffler's endocarditis, amyloid, Churg-Strauss). Focal myocardial late gadolinium enhancement is found in the specific cardiomyopathies, and the pattern is distinct from that seen in infarction. Further systematic studies are warranted to assess whether the pattern and extent of late enhancement may aid diagnosis and prognostic assessment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163027     DOI: 10.2459/01.JCM.0000296538.82763.f0

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  14 in total

Review 1.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

2.  Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.

Authors:  Piers C A Barker; Sara K Pasquali; Stephen Darty; Richard J Ing; Jennifer S Li; Raymond J Kim; Stephanie DeArmey; Priya S Kishnani; Michael J Campbell
Journal:  Mol Genet Metab       Date:  2010-07-23       Impact factor: 4.797

3.  Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-01       Impact factor: 2.357

4.  Hypertrophic Cardiomyopathy with Unusual Extensive Scarring Pattern: Danon Disease.

Authors:  Dan D Le; Paulino Alvarez; Roberto Barrios; Michael Arriaga; Mariyam Cherry; Dipan Shah; C Huie Lin
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 5.  Multimodality imaging in apical hypertrophic cardiomyopathy.

Authors:  Rosario Parisi; Francesca Mirabella; Gioel Gabrio Secco; Rossella Fattori
Journal:  World J Cardiol       Date:  2014-09-26

6.  A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging.

Authors:  L G Wei; J Q Gao; X M Liu; J M Huang; X Z Li
Journal:  Ir J Med Sci       Date:  2013-04-25       Impact factor: 1.568

7.  Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.

Authors:  Wei Li; Wei Liu; Jia Zhong; Xin Yu
Journal:  J Cardiovasc Magn Reson       Date:  2009-10-22       Impact factor: 5.364

8.  Left ventricular T2 distribution in Duchenne muscular dystrophy.

Authors:  Janaka P Wansapura; Kan N Hor; Wojciech Mazur; Robert Fleck; Sean Hagenbuch; D Woodrow Benson; William M Gottliebson
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-18       Impact factor: 5.364

9.  The effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic resonance imaging.

Authors:  Adam K McDiarmid; David A Broadbent; David M Higgins; Peter P Swoboda; Ananth Kidambi; David P Ripley; Bara Erhayiem; Tarique A Musa; Laura E Dobson; John P Greenwood; Sven Plein
Journal:  Quant Imaging Med Surg       Date:  2015-08

10.  Cardiovascular magnetic resonance findings in a case of Danon disease.

Authors:  Dorota Piotrowska-Kownacka; Lukasz Kownacki; Marek Kuch; Ewa Walczak; Agnieszka Kosieradzka; Anna Fidzianska; Leszek Krolicki
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-29       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.